James Strauss
Impact in
- Immunology top 10%
- interferon and immune responses
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- Immune cells in cancer
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
- Pancreatic and Hepatic Oncology Research
Papers in
- Oncology 40
- Cancer Immunotherapy and Biomarkers 20
- CAR-T cell therapy research 8
- Pancreatic and Hepatic Oncology Research 8
- Immunology 24
- Immunotherapy and Immune Responses 10
- interferon and immune responses 9
- Co-authors
- Joshua Brody (2 shared papers)Talia Golan (2 shared papers)Kevin J. Harrington (2 shared papers)Anuradha Khilnani (2 shared papers)Archie Tse (1 shared paper)Sašo Čemerski (1 shared paper)Aurélien Marabelle (1 shared paper)Eugene P. Frenkel (2 shared papers)
- Journals
- Journal of Clinical Oncology (28 papers)Annals of Oncology (9 papers)Cancer Research (5 papers)Clinical Cancer Research (2 papers)Journal for ImmunoTherapy of Cancer (2 papers)
- Partner nations
- United StatesUnited KingdomCanada
In The Last Decade
James Strauss
67 papers receiving 900 citations
Peers
Comparison fields: 5 of 90
- Immunology 397
- Oncology 363
- Biotechnology 51
- Internal Medicine 18
- Infectious Diseases 95
Countries citing papers authored by James Strauss
This map shows the geographic impact of James Strauss's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James Strauss with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James Strauss more than expected).
Fields of papers citing papers by James Strauss
This network shows the impact of papers produced by James Strauss. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James Strauss. The network helps show where James Strauss may publish in the future.
Co-authors
The 25 scholars most cited alongside James Strauss, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 72 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 216 | |
| 2 | 2023 | 101 | |
| 3 | 1995 | 71 | |
| 4 | 1993 | 48 | |
| 5 | 1996 | 46 | |
| 6 | 2022 | 30 | |
| 7 | 2021 | 30 | |
| 8 | 2023 | 24 | |
| 9 | 2025 | 21 | |
| 10 | 2023 | 19 | |
| 11 | 1980 | 18 | |
| 12 | 2012 | 17 | |
| 13 | 2021 | 17 | |
| 14 | 2024 | 17 | |
| 15 | 2018 | 14 | |
| 16 | 2022 | 13 | |
| 17 | 2020 | 13 | |
| 18 | 2021 | 13 | |
| 19 | 2020 | 12 | |
| 20 | 2020 | 10 |
About James Strauss
James Strauss is a scholar working on Oncology, Immunology, Biotechnology, Molecular Biology and Genetics, having authored 72 papers that have together received 926 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (20 papers), Cancer Research and Treatments (12 papers), Immunotherapy and Immune Responses (10 papers), interferon and immune responses (9 papers), CAR-T cell therapy research (8 papers), Pancreatic and Hepatic Oncology Research (8 papers), Virus-based gene therapy research (7 papers) and Monoclonal and Polyclonal Antibodies Research (5 papers). The work is most often cited by research in Immunology (397 citations), Oncology (363 citations), Biotechnology (51 citations), Internal Medicine (18 citations) and Infectious Diseases (95 citations). James Strauss has collaborated with scholars based in United States, United Kingdom and Canada. Frequent co-authors include Joshua Brody, Talia Golan, Kevin J. Harrington, Anuradha Khilnani, Archie Tse, Sašo Čemerski, Aurélien Marabelle, Eugene P. Frenkel, Barbara M. Osborne and Rodger L. Bick. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Cancer Research, Clinical Cancer Research and Journal for ImmunoTherapy of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.